Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Biotechnology

Health Care

Delphinus Medical Technologies, Inc.

Mark J Forchette

Thomas Boese

Erik West

Cuiping Li

Scott White

Peter Littrup

Heather Rone

Dane Baruzzini

The Leadership Team at Delphinus Medical Technologies, Inc. strategizes and oversees the company's operations, product development, clinical affairs, and market expansion. Comprised of key executives including the President & CEO, Chief Medical Officer, and Vice Presidents of various departments, this team ensures the successful development and commercialization of SoftVue, driving innovation and growth in breast cancer screening solutions.

Leadership Team

Engineering Team

Operations and Engineering Team

Leadership Team

About

Team members

Other teams at Delphinus Medical Technologies, Inc.

Engineering Team

Operations and Engineering Team